NCT03662607

Brief Summary

The primary aim of this study is to test the hypothesis that use of VR combined with standard procedural education will result in less pre-procedural anxiety than standard procedural education alone among patients undergoing first-time cardiac catheterization. The VR technology being evaluated in this study will allow patients to experience a 3-D simulation of certain aspects of their upcoming procedure prior to the actual procedure date.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 18, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2017

Completed
12 months until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2021

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

March 11, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

4.6 years

First QC Date

September 27, 2017

Results QC Date

January 7, 2025

Last Update Submit

April 2, 2026

Conditions

Keywords

preprocedureanxietycardiac catheterization

Outcome Measures

Primary Outcomes (1)

  • Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)

    The primary outcome of this study is patient anxiety, as measured by the State Trait Anxiety Inventory (STAI) score. STAI is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

    Change from baseline visit to procedure day. Baseline visits will occur up to 4 weeks prior to procedure.

Study Arms (2)

Control

NO INTERVENTION

Standard pre-procedural education for cardiac catheterization.

Treatment

EXPERIMENTAL

Standard pre-procedural education plus virtual reality experience for cardiac catheterization.

Behavioral: Virtual reality experience

Interventions

* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities) * Seated comfortably and free of direct obstruction * Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions. * Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology * When VR experience concluded, wellness self-assessment will be administered again.

Treatment

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled to undergo a left-heart catheterization procedure at the Meijer Heart Center
  • years of age
  • Signed study consent form

You may not qualify if:

  • History of cardiac procedure(s) in a cardiac catheterization laboratory
  • History of seizures, migraine headaches or severe susceptibility to motion sickness
  • Currently taking psychotropic drugs or on long-term psychotropic treatment
  • Unable to read and speak English
  • Visually impaired
  • Unable to provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spectrum Health

Grand Rapids, Michigan, 49503, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Results Point of Contact

Title
Dr. Ryan Madder
Organization
Spectrum Health

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 27, 2017

First Posted

September 7, 2018

Study Start

April 18, 2017

Primary Completion

November 29, 2021

Study Completion

December 31, 2025

Last Updated

April 14, 2026

Results First Posted

March 11, 2025

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

There are no plans to share data at this time.

Locations